Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study

• Główni autorzy: Giovanna Malara (Autor), Cristina Politi (Autor), Caterina Trifirò (Autor), Chiara Verduci (Autor), Graziella D'Arrigo (Autor), Alessandra Testa (Autor), Giovanni Tripepi (Autor)
• Format: Książka
• Wydane: Medical Journals Sweden, 2021-09-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Apremilast is an oral selective phosphodiesterase-4 inhibitor developed recently for psoriasis treatment. The aim of this study is to assess the real-life outcomes of use of apremilast in patients with psoriasis in everyday clinical practice. A total of 159 adult patients (90 males) with plaque psor...